| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000025159 |
| Receipt No. | R000028100 |
| Official scientific title of the study | Efficacy of expression treatment on o-MGD(obstructive meibomian gland dysfunction) |
| Date of disclosure of the study information | 2017/02/01 |
| Last modified on | 2017/09/08 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Efficacy of expression treatment on o-MGD(obstructive meibomian gland dysfunction) | |
| Title of the study (Brief title) | Efficacy of expression treatment | |
| Region |
|
|
| Condition | ||
| Condition | obstructive meibomian gland dysfunction | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We aim to elucidate the effectiveness of expression treatment on o-MGD |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Tear break up time (one month after the treatment) |
| Key secondary outcomes | Corneal and conjunctival staining score, DR-1 grade, Meibum expressibility with Shimazaki classification, Meibography |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -investigator(s) and assessor(s) are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Non-expressive treatments for one month(thermal therapy, lid hygiene, levofloxacin ophthalmic suspension 1.5% eyedrop qid, Fluorometholone ophthalmic suspension 0.1% tid, hyaluronic acid sodium ophthalmic suspension 0.1% qid, minocycline 200 mg po) | |
| Interventions/Control_2 | One month non-expressive treatment and single manual expression | |
| Interventions/Control_3 | One month non-expressive treatment and single mechanical expression | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients over 20 years old meeting the Japanese diagnostic definitions of MGD in 2010 who showed the obstruction of the meibomian glands and signd the informed consent | |||
| Key exclusion criteria | Patients who have undergone LASIK or cataract surgery within one year, wear contact lens, have systemic diseases related to dry eyes, use specific medication which may induce dry eye or MGD, have eye disease other than MGD, is pregnant or lactating | |||
| Target sample size | 24 | |||
| Research contact person | |
| Name of lead principal investigator | Naohiko Nakayama |
| Organization | Tokyo Dental College Ichikawa General Hospital |
| Division name | Department of Ophthalmology |
| Address | 5-11-13, Sugano, Ichikawa, Chiba |
| TEL | 047-322-0151 |
| nnakayama@tdc.ac.jp | |
| Public contact | |
| Name of contact person | Naohiko Nakayama |
| Organization | Tokyo Dental College Ichikawa General Hospital |
| Division name | Department of Ophthalmology |
| Address | 5-11-13, Sugano, Ichikawa, Chiba |
| TEL | 047-322-0151 |
| Homepage URL | |
| nnakayama@tdc.ac.jp | |
| Sponsor | |
| Institute | Tokyo Dental College Ichikawa General Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Tokyo Dental College Ichikawa General Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東京歯科大学市川総合病院(千葉県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028100 |